Strategic Collaboration between Biotage and Yingsheng on the Chinese Market for Clinical Mass Spectrometry Applications

04-Jun-2019 - Biotage AB announced its strategic collaboration with Shandong Yingsheng Biotechnology Co., Ltd.. Yingsheng is mainly focused on independently researching, producing and selling in vitro diagnostic reagents and medical equipment, building a genetic detection platform and mass spectrometry ...

Tomas Blomquist: New CEO & President of Biotage

28-May-2019 - Biotage has appointed Tomas Blomquist as the new CEO and President of Biotage AB. Tomas Blomquist, most recently Vice President EMEA Cardimetabolic at Abbott, will start his assignment on November 6, 2019, and will then take over the responsibility for the Biotage group and its + 400 employees. ...

Biotage acquires Horizon Technology

Strengthens position in environmental and food safety

08-Dec-2017 - Biotage AB has entered into an agreement to acquire all outstanding shares in the privately held company Horizon Technology, Inc. (Horizon) based in New Hampshire, US, at a purchase price of approx. USD 18.4 million, corresponding to approx. SEK 153 million, based on an enterprise value of ...

Biotage Awarded Patent for Flash Purification Method Development and Optimization

21-Apr-2010 - Biotage announced it has recently been awarded U.S. patent 7686959: Control system and Method for Flash Separation. The patented technology converts thin-layer chromatography (TLC) compound retention data into a linear gradient and also provides the user with sample loading estimates for any ...

Biotage AB Increases Focus on Environmental Market Segments

21-Feb-2008 - Biotage AB announced plans to increase its focus on growing business opportunities in the environmental analysis business. The strategy includes redeployed marketing and sales resources along with new product development for specific application areas. In late 2007 Biotage launched EVOLUTE ABN ...

Biotage AB Signs Two Exclusive Agreements with Reaxa

20-Jan-2006 - Under a first agreement between Reaxa and Biotage both companies will develop "MicroEnCat(tm)" an encapsulated palladium catalyst range optimized for use in Biotage's Microwave Synthesizers, including the development of prefilled microwave vials and flow-through devices. A second agreement offers ...

Biotage AB acquires rights to novel Evaporation system from Vapourtec, Ltd.

13-Jan-2006 - Biotage has acquired the exclusive distribution, production and further development rights to Vapourtecs solvent evaporation system, known as the V-10. The agreement also provides for Vapourtec to deliver further developments and line extensions for the product within 2006. The purchase price ...

Biotage AB Acquires Separtis Holding AG for 1.4M Euros (13M SEK) and Completes EU Distribution Consolidation

11-Oct-2005 - Biotage has acquired Separtis Holding AG, the Swiss, German and Austrian distributor for many Biotage products, formerly the Argonaut Technologies consumable product range. Under the terms of the agreement Biotage will retain all current Separtis employees, assume the leased facilities in ...

Biotage has received its largest order to date

15-Aug-2005 - Biotage has received the company's largest single order to date. It includes 31 instruments and totals approx. 15 MSEK. The customer is one of the world's major pharmaceutical companies. The instruments, which originate from the recently acquired company Argonaut, will be used by chemists to ...

Argonaut Technologies' Stockholders Approve Sale of Assets to Biotage

03-Jun-2005 - Argonaut Technologies announced that its stockholders have approved the sale of the assets of its chemistry consumables business and certain assets of its process chemistry business, which constitute substantially all of its assets except for its cash, to Biotage AB of Uppsala, Sweden. Argonaut ...